WebApr 5, 2024 · CABG is evolving. Multiarterial grafting is becoming a favored approach in coronary artery bypass graft surgery (CABG), with evidence mounting that graft patency and clinical outcomes are improved over saphenous vein or single internal thoracic artery grafts. At Cleveland Clinic, Dr. Bakaeen notes, multiarterial grafting is the default ... WebMay 19, 2016 · Coronary-artery bypass grafting (CABG) is a procedure in which autologous arteries or veins are used as grafts to bypass coronary arteries that are partially or completely obstructed by atheroscler...
循環器学用語集
WebAug 26, 2014 · The three-year primary graft patency rates were (non-significantly) higher in the anticoagulant therapy cohort compared with the aspirin monotherapy group (75% vs. 51%, P = 0.4). There were no … WebApr 1, 2024 · The use of this method, called hybrid surgery, to treat complex or giant intracranial aneurysms has also been accepted by neurosurgeons increasingly. 32-34 Our previous study revealed that STA grafts showed good patency after STA-MCA bypass surgery in patients with intracranial aneurysms and that the mean flow could be … flag shield logo
Graft patency after FFR-guided versus angiography-guided …
WebDec 4, 2024 · Approximately 2 years ago, we launched the Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET) trial (ClinicalTrials.gov Identifier: NCT02053909) to evaluate the potential benefits of ticagrelor 90 mg twice daily, compared with aspirin 81 mg twice daily, on 1- and 2-year graft patency after CABG. 15 Given the … WebSep 14, 2024 · Comment. Despite efforts of pursuing total arterial revascularization, 2 SVGs still represent the most commonly used grafts during CABG procedures. 3 Although advances in surgical techniques and pharmacotherapy have improved the long-term graft patency rates, SVG failure remains a frequent occurrence, being observed in 3–12% of … WebThe patency of femoropopliteal bypass with autologous saphenous vein was ~50% at 10 years, an attrition of 5% per year [108]. With glutaraldehyde-stabilized human umbilical cord grafts, the patency rate at 37 months was 63% in the femoropopliteal position, 54% in the distal tibial position, and 32% in the peroneal site [105]. Thus in general ... flag shield image